Journal List > Infect Chemother > v.44(5) > 1035178

Heo, Kim, Cha, Lee, Shim, and Choe: A Clinical features of Severe Adenovirus Pneumonia among Members of the Korea Military: A Case Series

Abstract

Background

Adenoviral diseases generally present as self-limiting upper respiratory illnesses. However, in some cases, adenovirus can cause fatal outcomes, even in healthy adults. Severe pneumonia caused by adenovirus in young soldiers at basic military training sites have been reported.

Materials and Methods

We conducted a retrospective review of the medical records of patients with pneumonia who were hospitalized in the Intensive Care Unit of the Armed Forces Capital Hospital between January 2011 and March 2012.

Results

Nine patients with pneumonia who required ventilator treatment were analyzed. Adenovirus was proved to be the causative agent of the illness in six out of nine patients, three of whom died due to severe adenoviral pneumonia or adenovirus-related illness. Among these six patients, three were military trainees. Clinical features were characterized by fever (100%) and cough (100%). Other important findings included thrombocytopenia (83.3%), leukopenia (66.6%), and radiologically lobar consolidation (66.7%).

Conclusions

Adenovirus appeared to be the most important pathogen of young Korean soldiers, particularly among military trainees with severe pneumonia requiring mechanical ventilation. Outbreak surveillance for adenovirus associated illness is necessary.

Figures and Tables

Figure 1
Serial Chest X-ray of Case No. 2 on the (A) 1st hospital day, (B) 3rd hospital day, and (C) 5th hospital day, and (D) chest CT scan on the 5th hospital day: Despite antibiotics and antiviral treatment, pneumonia on the right lung field showed rapid deterioration.
ic-44-372-g001
Table 1
Characteristics, Clinical Feature and Outcome of Patients with Severe Adenovirus Pneumonia
ic-44-372-i001

BAL, Bronchoalveolar lavage; ARDS, Acute respiratory distress syndrome; HD, Hospital day

Table 2
Laboratory Values and Radiological Findings of Six Pneumonia Patients on Admission to Intensive Care Unit
ic-44-372-i002

WBC, White blood cell; Hgb, Hemoglobin; ESR, Erythrocyte sedimentation rate; CRP, C-reactive protein

References

1. Lynch JP 3rd, Fishbein M, Echavarria M. Adenovirus. Semin Respir Crit Care Med. 2011. 32:494–511.
crossref
2. Rhee EG, Barouch DH. Mandell GL, Douglas RG, Bennett JE, editors. Adenoviruses. Principles and practice of infectious disease. 2009. 7th ed. Philadelphia: Churchill Livingstone;2029–2030.
crossref
3. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis. 2006. 43:331–339.
4. Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med. 2007. 28:222–242.
crossref
5. Dudding BA, Wagner SC, Zeller JA, Gmelich JT, French GR, Top FH Jr. Fatal pneumonia associated with adenovirus type 7 in three military trainees. N Engl J Med. 1972. 286:1289–1292.
crossref
6. Pingleton SK, Pingleton WW, Hill RH, Dixon A, Sobonya RE, Gertzen J. Type 3 adenoviral pneumonia occurring in a respiratory intensive care unit. Chest. 1978. 73:554–555.
crossref
7. Klinger JR, Sanchez MP, Curtin LA, Durkin M, Matyas B. Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med. 1998. 157:645–649.
crossref
8. Hilleman MR, Werner JH, Dascomb HE, Butler RL. Epidemiologic investigations with respiratory disease virus RI-67. Am J Public Health Nations Health. 1955. 45:203–210.
crossref
9. Friedman M, Grayston JT, Loosli CG, Pierce WE, Whiteside JE, Woolridge RL. Studies on acute respiratory illness in naval recruits, with emphasis on the adenoviruses. J Infect Dis. 1956. 99:182–187.
10. Jeon K, Kang CI, Yoon CH, Lee DJ, Kim CH, Chung YS, Kang C, Choi CM. High isolation rate of adenovirus serotype 7 from South Korean military recruits with mild acute respiratory disease. Eur J Clin Microbiol Infect Dis. 2007. 26:481–483.
crossref
11. Brosch L, Tchandja J, Marconi V, Rasnake M, Prakash V, McKnight T, Bunning M. Adenovirus serotype 14 pneumonia at a basic military training site in the United States, spring 2007: a case series. Mil Med. 2009. 174:1295–1299.
crossref
12. Kolavic-Gray SA, Binn LN, Sanchez JL, Cersovsky SB, Polyak CS, Mitchell-Raymundo F, Asher LV, Vaughn DW, Feighner BH, Innis BL. Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis. 2002. 35:808–818.
crossref
13. Kim JH, Kwak YH, Na BK, Lee JY, Shin GC, Jung HS, Hong JY, Oh MD, Cheong HJ, Kim MJ, Pai HJ, Kim YR, Shin WS, Kang JM, Woo JH, Uh ST, Lee HJ. Viral etiology of community-acquired pneumonia in Korean adults. Korean J Infect Dis. 2001. 33:8–14.
14. Kim CK, Chung CY, Kim JS, Lee HJ. A study of adenovirus pneumonia: early summer outbreak in 1996. Korean J Pediatr Infect Dis. 1996. 3:145–153.
crossref
15. Lee J, Choi EH, Lee HJ. Comprehensive serotyping and epidemiology of human adenovirus isolated from the respiratory tract of Korean children over 17 consecutive years (1991-2007). J Med Virol. 2010. 82:624–631.
crossref
16. Hakim FA, Tleyjeh IM. Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature. Eur J Clin Microbiol Infect Dis. 2008. 27:153–158.
crossref
17. Naesens L, Lenaerts L, Andrei G, Snoeck R, Van Beers D, Holy A, Balzarini J, De Clercq E. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother. 2005. 49:1010–1016.
crossref
18. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007. 13:74–81.
crossref
19. Gaydos CA, Gaydos JC. Adenovirus vaccines in the U.S. military. Mil Med. 1995. 160:300–304.
crossref
20. Potter RN, Cantrell JA, Mallak CT, Gaydos JC. Adenovirus-associated deaths in US military during postvaccination period, 1999-2010. Emerg Infect Dis. 2012. 18:507–509.
crossref
21. US Food and Drug Administration, US Department of Health and Human Services. Vaccines, blood, and biologics. March 16, 2011 approval letter-adenovirus type 4 and type 7 vaccine, live, oral. Accessed 21 May 2012. Available at http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm247511.htm.
TOOLS
ORCID iDs

Jung Yeon Heo
https://orcid.org/http://orcid.org/0000-0002-6548-1939

Similar articles